Elucidating the Role of Metals in Alzheimer’s Disease Through the Use of Surface-Enhanced Laser Desorption/Ionisation Time-of-Flight Mass Spectrometry

Methods in Molecular Biology

Volumn 752, Issue , 2011, Pages 229-240

  Watt, Andrew D ^a   Perez, Keyla A ^b   Hung, Lin Wai ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NONE

Author keywords

Alzheimer s disease; Antibody capture; A ; Immobilised metal affinity capture; Metal homeostasis; SELDI TOF MS

Indexed keywords

AMYLOID BETA PROTEIN; ANTIBODY; COUMARIC ACID; IMMOBILIZED PROTEIN; METAL; SINAPIC ACID;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; CHEMISTRY; HUMAN; IMMUNOLOGY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOUSE; SURFACE PROPERTY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIBODIES; COUMARIC ACIDS; HUMANS; IMMOBILIZED PROTEINS; METALS; MICE; MICE, TRANSGENIC; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURFACE PROPERTIES;

EID: 79960995384     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60327-223-0_15     Document Type: Chapter

References (41)

1. Gravina, S.A., et al., Amyloid b protein (A b) in Alzheimer’s disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Ab40 or Ab42(43). Journal of Biological Chemistry, 1995. 270: p. 7013–7016.
2. Kosik, K.S., C.L. Joachim, and D.J. Selkoe, Microtubule-associated protein tau (t) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A, 1986. 83: p. 4044–4048.
3. Chetelat, G., et al., Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer’s disease. Brain, 2008. 131(1): p. 60–71.
4. Masters, C.L., et al., Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A, 1985. 82: p. 4245–4249.
5. Glenner, G.G. and C.W. Wong, Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun, 1984. 120: p. 885–890.
6. Goldgaber, D., et al., Isolation, characterization and chromosomal localization of human brain cDNA clones coding for the precursor of the amyloid of brain in Alzheimer’s disease, Down’s syndrome and aging. Journal of Neural Transmission, 1987. 24: p. 23–28.
7. Kang, J., et al., The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature, 1987. 325: p. 733–736.
8. Robakis, N.K., et al., Molecular cloning and characterization of a cDNA encoding the cerebrovascular and neuritic plaque amyloid peptides. Proc Natl Acad Sci U S A, 1987. 84: p. 4190–4194.
9. Tanzi, R.E., et al., Amyloid b protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science, 1987. 235: p. 880–884.
10. Blennow, K., M.J. de Leon, and H. Zetterberg, Alzheimer’s disease. Lancet, 2006. 368(9533): p. 387–403.
11. Zhang, Y.-W. and H. Xu, Molecular and Cellular Mechanisms for Alzheimer’s Disease: Understanding APP Metabolism. Current Molecular Medicine, 2007. 7(7): p. 687–696.
12. Prelli, F., et al., Different processing of Alzheimer’s b-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type. Biochemical and Biophysical Research Communications, 1988. 151: p. 1150–1155.
13. Bica, L., et al., Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer’s disease. Molecular Biosystems, 2009. 5(2): p. 134–142.
14. Masters, C.L., et al., Molecular mechanisms for Alzheimer’s disease: implications for neuroim-aging and therapeutics. J Neurochem, 2006. 97(6): p. 1700–1725.
15. Jellinger, K.A., et al., Biomarkers for Early Diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’-A New Blood Biomarker? Journal of Cellular and Molecular Medicine, 2008. 12(4): p. 1094–1117.
16. Crouch, P.J., A.R. White, and A.I. Bush, The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer’s disease. FEBS Journal, 2007. 274(15): p. 3775–3783.
17. Bush, A.I. and R.E. Tanzi, Therapeutics for Alzheimer’s disease based on the metal hypothesis. Neurotherapeutics, 2008. 5(3): p. 421–432.
18. Massie, H.R., V.R. Aiello, and A.A. Iodice, Changes with age in copper and superoxide-dis-mutase levels in brains of C57BL-6J mice. Mechanisms of Ageing and Development, 1979. 10(1–2): p. 93–99.
19. Maynard, C.J., et al., Overexpression of Alzheimer’s disease amyloid-b opposes the age-dependent elevations of brain copper and iron. J Biol Chem, 2002. 277(47): p. 44670–6.
20. Takahashi, S., et al., Age-related changes in the concentrations of major and trade elements in the brain of rats and mice. Biological Trace Element Research, 2001. 80(2): p. 145–158.
21. Barnham, K.J., C.L. Masters, and A.I. Bush, Neurodegenerative diseases and oxidative stress. Nature Reviews Drug Discovery, 2004. 3(3): p. 205–214.
22. Barnham, K.J., et al., Metal-Protein Attenuating Compounds (MPACs) for the Treatment of Alzheimer’s Disease. Drug Design Reviews-Online, 2004. 1: p. 75–82.
23. Finefrock, A.E., Bush, A.I., and P.M. Doraiswamy, Current status of metals as therapeutic targets in Alzheimer’s disease. J Am Geriatr Soc, 2003. 51(8): p. 1143–1148.
24. Atwood, C.S., et al., Characterization of copper interactions with Alzheimer amyloid b peptides: identification of an attomolar-affinity copper binding site on amyloid b1-42. J Neurochem, 2000. 75: p. 1219–1233.
25. 2 . J Biol Chem, 2002. 277(43): p. 40302–40308.
26. Adlard, P.A., et al., Rapid restoration of cognition in Alzheimer’s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron, 2008. 59(1): p. 43–55.
27. Crouch, P.J., et al., Increasing Cu bioavailabil-ity inhibits A beta oligomers and tau phosphorylation. Proceedings of the National Academy of Sciences of the United States of America, 2009. 106(2): p. 381–386.
28. Hanger, D.P., et al., Glycogen synthase kinase-3 induces Alzheimer’s disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett, 1992. 147(1): p. 58–62.
29. White, A.R., et al., Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity. Journal of Biological Chemistry, 2006. 281(26): p. 17670–17680.
30. Issaq, H.J., et al., SELDI-TOF MS for diagnostic proteomics. Analytical Chemistry, 2003. 75(7): p. 148A–155A.
31. Whelan, L.C., et al., Applications of SELDI-MS technology in oncology. Journal of Cellular and Molecular Medicine, 2008. 12(5A): p. 1535–1547.
32. Hutchens, T.W. and T.T. Yip, New Desorption Strategies for the Mass-Spectrometric Analysis of Macromolecules. Rapid Communications in Mass Spectrometry, 1993. 7(7): p. 576–580.
33. Merchant, M. and S.R. Weinberger, Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis, 2000. 21(6): p. 1164–1177.
34. Wittke, S., T. Kaiser, and H. Mischak, Differential polypeptide display: the search for the elusive target. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 2004. 803(1): p. 17–26.
35. ® System. Nature Methods, 2005. 2(5): p. 393–395.
36. Geng, T., et al., Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal. Journal of Neuroscience Methods, 2006. 158(1): p. 1–12.
37. Bio-Rad Laboratories, I., ProteinChip IMAC30 Array (Immobilized Metal Affinity Capture)-Instruction Manual, I. Bio-Rad Laboratories, Editor. 2006.
38. Qin, W., et al., S100A7, a Novel Alzheimer’s Disease Biomarker with Non-Amyloidogenic a-Secretase Activity Acts via Selective Promotion of ADAM-10. PLoS ONE, 2009. 4(1): p. e4183.
39. Simonsen, A.H., et al., Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer’s disease. Neurobiology of Aging, 2008. 29(7): p. 961–968.
40. Hung, L.W., et al., Amyloid-beta peptide (Abeta) neurotoxicity is modulated by the rate of peptide aggregation: Abeta dimers and trimers correlate with neurotoxicity. J Neurosci, 2008. 28(46): p. 11950– 11958.
41. Giannakis, E., et al., Analysis of Ab Interactions Using ProteinChip Technology. Methods Mol Biol, 2008. p. 71–86.